Smartphone algorithm for anemia, increased costs of metastatic breast cancer

New research found that an algorithm for detecting anemia using smartphone photos worked with 72.6% accuracy. That was the big story in hematology / oncology last week.

Another great story included the results of a study into metastatic breast cancer. The researchers hypothesized that the total annual costs of metastatic breast cancer could increase due to the estimated increase in cases in younger women.

Read these articles and many more in hematology / oncology below:

Algorithm can detect anemia from smartphone photos of the inner eyelid

Anemia is a global public health problem that carries a significant risk of mortality and morbidity, especially in the elderly, children and those with chronic diseases. Read more.

Costs of metastatic breast cancer could jump 140% by 2030

The total annual costs associated with metastatic breast cancer in the United States could exceed $ 152 billion by 2030, according to a study published in JNCI Cancer Spectrum. Read more.

Screening method frequently misses endometrial cancer in black women

Transvaginal ultrasound used to determine the suitability of endometrial cancer biopsy missed nearly five times as many cases of the disease in black women compared to white women, according to a mock cohort study published in JAMA Oncology. Read more.

The MD Anderson Cancer Center at the University of Texas again named the best cancer hospital in the United States

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. Read more.

Bristol Myers Squibb Withdraws Liver Cancer Indication For Nivolumab

Bristol Myers Squibb, in consultation with the FDA, has voluntarily withdrawn the indication for nivolumab (Opdivo) as monotherapy for patients with hepatocellular carcinoma previously treated with sorafenib (Nexavar, Bayer). Read more.